0 CHECKOUT

PRODUCT FILTERS

REGION

12,643
9,443
9,370
8,719
8,676

COUNTRY

8,290
1,130
507
473
398

CATEGORIES

  • 2,926
  • 2,596
  • 2,224
  • 2,072
  • 2,071
  • 1,879
    • 353
    • 265
    • 257
    • 254
    • 216
    • 209
    • 181
    • 162
    • 160
    • 148
    • 145
    • 136
    • 100
    • 98
  • 1,480
  • 1,414
  • 1,346
  • 1,291
  • 1,277
  • 1,016
  • 1,005
    • 250
  • 936
  • 592
  • 557
  • 514
  • 407
  • 384
    • 406
      • 57
    • 113
  • 377
  • 163
  • 131
SHOW ALL

PRICE

5,143
10,009
16,654
32,485

PUBLISHED

2,178
7,481
15,723
32,485

PRODUCT TYPE

25,561
2,714
2,559
729
530
223
70
42
29
20
6
1
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. Show Less Read more

Endometriosis - Pipeline Review, H1 2016

Endometriosis - Pipeline Review, H1 2016 Summary ‘Endometriosis - Pipeline Review, H1 2016’, provides an overview of the Endometriosis pipeline landscape. The report provides comprehensive information...

Published:  March 2016
Price:  From

Pre-Eclampsia - Pipeline Review, H1 2016

Pre-Eclampsia - Pipeline Review, H1 2016 Summary ‘Pre-Eclampsia - Pipeline Review, H1 2016’, provides an overview of the Pre-Eclampsia pipeline landscape. The report provides comprehensive information...

Published:  March 2016
Price:  From

Pharmaceutical Wholesaling in the UK

Pharmaceutical Wholesaling in the UK This industry covers businesses that wholesale pharmaceuticals or medical goods. These are distributed to pharmacies, specialist retailers, hospitals, doctors...

Published:  October 2015
Price:  From

Melanoma Drug Pipeline Update

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced...

Published:  February 2016
Price:  From

Hematological Cancers Drug Pipeline Update

Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity. There are today 675 companies plus partners developing...

Published:  February 2016
Price:  From

Cancer Vaccines Drug Pipeline Update

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit...

Published:  February 2016
Price:  From

Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update

The Alpha6 Beta4 Integrin signaling pathway activates the PI 3-kinase/Akt, MAPK/NFkB and SMAD signaling modules. There are today 370 companies plus partners developing 510 Alpha6Beta4 integrin pathway...

Published:  February 2016
Price:  From

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 440 companies plus partners developing 539 Androgen Receptor drugs in 1743 developmental projects in cancer....

Published:  February 2016
Price:  From

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several...

Published:  February 2016
Price:  From

Biologicals in Oncology Drug Pipeline Update

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 1334 companies plus partners developing 2611...

Published:  February 2016
Price:  From

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 532 companies plus partners developing 802 EGFR1 pathway targeting drugs in 2875 developmental projects in...

Published:  February 2016
Price:  From

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 161 companies plus...

Published:  February 2016
Price:  From

ID Signaling Pathway in Oncology Drug Pipeline Update

Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding...

Published:  February 2016
Price:  From

IL-1 Signaling Pathway in Oncology Drug Pipeline Update

The IL-1 signaling pathway activates the MAPK/JNK signaling modules. The MAPK pathway leads to activation of NFkB complex. As both IL-1 and TNF alpha stimulate the MAPK signaling module and activate...

Published:  February 2016
Price:  From

IL-2 Signaling Pathway in Oncology Drug Pipeline Update

The IL-2 signaling pathway activates the Ras/MAPK, JAK/Stat and PI 3-kinase/Akt signaling modules. There are today 325 companies plus partners developing 419 IL-2 pathway targeting drugs in 1525 developmental...

Published:  February 2016
Price:  From

IL-3 Signaling Pathway in Oncology Drug Pipeline Update

The IL-3 signaling pathway activates the JAK/STAT, MAPK and PI 3-kinase signaling modules. There are today 236 companies plus partners developing 306 IL-3 pathway targeting drugs in 1158 developmental...

Published:  February 2016
Price:  From

IL-4 Signaling Pathway in Oncology Drug Pipeline Update

The IL-4 signaling pathway stimulates the JAK/STAT and MAPK signaling modules. There are today 204 companies plus partners developing 262 IL-4 pathway targeting drugs in 951 developmental projects...

Published:  February 2016
Price:  From

IL-5 Signaling Pathway in Oncology Drug Pipeline Update

The IL-5 singaling pathway activates the JAK/STAT and Raf/MAPK signaling modules. There are today 160 companies plus partners developing 199 IL-5 pathway targeting drugs in 865 developmental projects...

Published:  February 2016
Price:  From

IL-6 Signaling Pathway in Oncology Drug Pipeline Update

The IL-6 signaling pathway activates the Jak/STAT, Ras/Raf/MAPK and PI 3-kinase signaling modules. There are today 365 companies plus partners developing 438 IL-6 pathway targeting drugs in 1496 developmental...

Published:  February 2016
Price:  From

IL-7 Signaling Pathway in Oncology Drug Pipeline Update

IL-7 signaling pathway mainly activates the JAK/STAT signaling module. There are today 87 companies plus partners developing 90 IL-7 pathway targeting drugs in 369 developmental projects in cancer....

Published:  February 2016
Price:  From
Loading Indicator

Our Clients